257 related articles for article (PubMed ID: 29997145)
1. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
Venn A; Watson L; Bruinsma F; Giles G; Healy D
Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
[TBL] [Abstract][Full Text] [Related]
4. Breast and ovarian cancer incidence after infertility and in vitro fertilisation.
Venn A; Watson L; Lumley J; Giles G; King C; Healy D
Lancet; 1995 Oct; 346(8981):995-1000. PubMed ID: 7475593
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence following treatment for infertility at a clinic in the UK.
Doyle P; Maconochie N; Beral V; Swerdlow AJ; Tan SL
Hum Reprod; 2002 Aug; 17(8):2209-13. PubMed ID: 12151460
[TBL] [Abstract][Full Text] [Related]
6. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
7. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
[TBL] [Abstract][Full Text] [Related]
8. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
Goedert JJ; Schairer C; McNeel TS; Hessol NA; Rabkin CS; Engels EA;
Br J Cancer; 2006 Sep; 95(5):642-8. PubMed ID: 16868538
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors and cancers of the breast and genital organs--are the different cancer sites similarly affected?
Kvåle G; Heuch I; Nilssen S
Cancer Detect Prev; 1991; 15(5):369-77. PubMed ID: 1751947
[TBL] [Abstract][Full Text] [Related]
11. Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in Shanghai.
Zheng W; Shu XO; McLaughlin JK; Chow WH; Gao YT; Blot WJ
Cancer; 1993 Jun; 71(11):3620-4. PubMed ID: 8490910
[TBL] [Abstract][Full Text] [Related]
12. Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89.
Jin F; Shu XO; Devesa SS; Zheng W; Blot WJ; Gao YT
Cancer Causes Control; 1993 Jul; 4(4):355-60. PubMed ID: 8347785
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study.
Schoemaker MJ; Swerdlow AJ; Higgins CD; Wright AF; Jacobs PA;
Lancet Oncol; 2008 Mar; 9(3):239-46. PubMed ID: 18282803
[TBL] [Abstract][Full Text] [Related]
14. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
15. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
van den Belt-Dusebout AW; Spaan M; Lambalk CB; Kortman M; Laven JS; van Santbrink EJ; van der Westerlaken LA; Cohlen BJ; Braat DD; Smeenk JM; Land JA; Goddijn M; van Golde RJ; van Rumste MM; Schats R; Józwiak K; Hauptmann M; Rookus MA; Burger CW; van Leeuwen FE
JAMA; 2016 Jul; 316(3):300-12. PubMed ID: 27434442
[TBL] [Abstract][Full Text] [Related]
17. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
18. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study.
Vassard D; Schmidt L; Glazer CH; Lyng Forman J; Kamper-Jørgensen M; Pinborg A
Hum Reprod; 2019 Nov; 34(11):2290-2296. PubMed ID: 31600391
[TBL] [Abstract][Full Text] [Related]
19. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.
Reulen RC; Frobisher C; Winter DL; Kelly J; Lancashire ER; Stiller CA; Pritchard-Jones K; Jenkinson HC; Hawkins MM;
JAMA; 2011 Jun; 305(22):2311-9. PubMed ID: 21642683
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study.
Mogensen JB; Kjær SK; Mellemkjær L; Jensen A
Gynecol Oncol; 2016 Oct; 143(1):87-92. PubMed ID: 27430396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
